research Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Porto, Portugal
Fortaleza, CE, Brazil
Brasília, DF, Brazil
São Paulo, SP, Brazil
Navi Mumbai, Maharashtra, India
Dubai, United Arab Emirates